Omeros Logo     Print Page  |  Close Window

Investor Relations Home

Corporate Profile

Here you will find financial reports and shareholder information about Omeros Corporation, including recent news, current and historical share price, and electronic copies of our SEC filings.

 
Stock Quote
OMER (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$16.09
Change (%) Stock is Up 0.24 (1.51%)
Volume406,786
Data as of 05/24/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent Press ReleasesMore >>
DateTitle  
05/17/17Omeros Announces Completion of IgA Nephropathy Cohort in OMS721 Phase 2 Clinical Trial
-- Additional Positive Results Support Rapid Advancement to Phase 3 Trial -- SEATTLE--(BUSINESS WIRE)--May 17, 2017-- Omeros Corporation (NASDAQ: OMER) today announced completion of the IgA nephropathy cohort and reported additional positive results from the first stage of the company’s Phase 2 clinical trial of OMS721 for the treatment of serious kidney disorders. All patients in the cohort have now completed the OMS721 treatment and follow-u... 
 Printer Friendly Version
05/10/17Omeros Corporation Reports First Quarter 2017 Financial Results
-- Conference Call Today at 4:30 p.m. ET -- SEATTLE--(BUSINESS WIRE)--May 10, 2017-- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced recent highlights and developments as well as fina... 
 Printer Friendly Version
05/03/17Omeros Corporation to Announce First Quarter 2017 Financial Results on May 10, 2017
SEATTLE--(BUSINESS WIRE)--May 3, 2017-- Omeros Corporation (NASDAQ:OMER), today announced that the company will issue its first quarter 2017 financial results for the period ended March 31, 2017, on Wednesday, May 10, 2017, after the market closes. Omeros management will host a conference call and webcast that day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results. Conference Call Details To ... 
 Printer Friendly Version
04/03/17Omeros to Present at the Needham Healthcare Conference
SEATTLE--(BUSINESS WIRE)--Apr. 3, 2017-- Omeros Corporation (NASDAQ: OMER) today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the 16th Annual Needham Healthcare Conference in New York City this week. The presentation is scheduled for Wednesday, April 5, 2017 at 12:10 p.m. EDT. The presentation will be webcast. The live and archived webcasts can be accessed on the “Events” page of the comp... 
 Printer Friendly Version
Upcoming EventsMore >>
DateTitle
06/16/17 10:00 a.m. PT
Omeros Corporation Annual Shareholder Meeting
LocationWorld Trade Center Seattle
2200 Alaskan Way, Suite 410
Seattle, WA 98121
Featured Report
Download Documentation 2016 Annual Report
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Omeros Corporation posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.